InflaRx
$2.689876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.15 (-5.28%) Today
-$0.01 (-0.37%) As of 6:46 PM EDT after-hours
Why Robinhood?
You can buy or sell InflaRx and other stocks, options, ETFs, and crypto commission-free!
About IFRX
InflaRx N.V. Common Stock, also called InflaRx, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Read More Its products includes IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Employees
38,000
Headquarters
Jena, Thueringen
Founded
2007
Market Cap
69.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
760.29K
High Today
$2.88
Low Today
$2.68
Open Price
$2.81
Volume
553.17K
52 Week High
$53.10
52 Week Low
$2.45
Collections
Price Paid on Robinhood
93% Lower
Right Now
52 Week Low
$20.31
Average Price Paid
$37.03
52 Week High
$53.10
Analyst Ratings
0%
of 7 ratings
Buy
0%
Hold
71%
Sell
29%
IFRX Earnings
-$0.65
-$0.47
-$0.30
-$0.12
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
-$0.65 per share